ReviewAdvanced healthcare materials2026
Microphysiological Systems of Lymphatics and Immune Organs.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Using Organoids to Unlock the Potential of Human Torpor for Spaceflight.Current stem cell reports · 2026Article
- Engineering Lymphatic Vessels and Lymphoid Microenvironments In Vitro to Investigate Immune Cell Trafficking.Current opinion in biomedical engineering · 2026Article
- Organoid: a promising solution to current challenges in cancer immunotherapy.npj biomedical innovations · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Microphysiological systems (MPS) that incorporate engineered blood vasculatures have enabled new opportunities to study human physiology and disease, offering platforms for drug development, tissue modeling, and regenerative medicine. However, most human tissues also contain an equally complex yet underrepresented secondary vascular network, the lymphatic system. Lymphatics play indispensable roles in interstitial fluid drainage, immune cell trafficking, and antigen presentation, and are central to the pathophysiology of diseases such as lymphedema, chronic inflammation, and cancer metastasis. Despite their critical biological functions, lymphatic vessels and associated immune structures, such as lymph nodes, remain absent from current in vitro models. Integrating lymphatics into biomaterials-based MPS is essential for capturing the dynamic interplay between fluid transport, immune surveillance, and tissue homeostasis. This review surveys recent progress in engineering lymphatic microenvironments and immune organoids within biomaterials-based MPS, emphasizing innovative strategies to recreate the biochemical and biophysical complexity of native lymphatic tissues. Advances are highlighted in tunable extracellular matrix platforms, humanized cell sourcing, and precision fabrication techniques, including perfusable, modular, and scalable models. The integration of lymphatic components with multi-organ systems, combined with the application of computational modeling and machine learning, offers unprecedented opportunities to build personalized and physiologically relevant immune models. Incorporating lymphatics into next-generation MPS promises to illuminate fundamental disease mechanisms and accelerate the development of more predictive therapeutic testing platforms with improved clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.